Events

MaRS Future of Medicine™ Conference 2011

When:
Nov 17, 2011 
Where:

MaRS Centre
101 College Street
Toronto, ON

Now in its third great year, the 2011 MaRS Future of Medicine™ Annual Conference will feature exciting advances in two major themes:

Neuroscience

  • Insights into pain and addiction
  • How Toronto is emerging as a world leader in brain science
  • New approaches for Alzheimer’s Disease and ALS

Access to Innovation

  • With over $1.0 billion in annual research support the Discovery District of Toronto is a global centre of excellence in multiple life sciences sectors
  • Listen and learn from the leaders of the organizations charged with translating our research excellence into the major health solutions of tomorrow

Confirmed speakers include:

  • Michael Salter, Head of Neurosciences & Mental Health, Hospital for Sick Children
  • Neil Cashman, CSO & Co-Founder, Amorfix Life Sciences Ltd
  • Fang Liu, Head of Molecular Neuroscience, Centre for Addiction and Mental Health
  • Thomas Hudson, President & Scientific Director, Ontario Institute for Cancer Research
  • Michael May, CEO, Centre for Commercialization of Regenerative Medicine
  • John Soloninka, President & CEO, The Health Technology Exchange (htx.ca)
  • Rafi Hofstein, President & CEO, MaRS Innovation
  • Kenneth Galbraith, General Partner, Ventures West

We look forward to seeing you at the MaRS Future of Medicine™ 2011 Annual Conference!

Click here for more information and registration>>

Part of the MaRS Future of Medicine™ Series



 

In This Series

Past Events

MaRS Programming
May 14, 2012
MaRS Future of Medicine™
Assessing Breast Cancer Risk
>
MaRS Programming
Apr 11, 2012
MaRS Future of Medicine™
Why did they invest in that?
>
MaRS Programming
Mar 13, 2012
MaRS Future of Medicine™
How Digital Tools are Transforming the Way We Do Science
>
MaRS Programming
Feb 14, 2012
MaRS Future of Medicine™
Personalized Cancer Treatment
>
MaRS Programming
Jan 10, 2012
MaRS Future of Medicine™
The Renaissance of Gene Therapy
>
MaRS Programming
Nov 24, 2011
MaRS Future of Medicine™
Building a Self-Sustaining Medical Research Engine: The Ontario Cancer Biomarker Network
>
MaRS Programming
Nov 17, 2011
MaRS Future of Medicine™
MaRS Future of Medicine™ Conference 2011
>
MaRS Programming
Oct 27, 2011
MaRS Future of Medicine™
Financing Early Stage Companies in Challenging Times
>
MaRS Programming
Sep 29, 2011
MaRS Future of Medicine™
Truths and Myths about Life Science Venture Capital
>
MaRS Programming
Aug 25, 2011
MaRS Future of Medicine™
Teaching old drugs new tricks – developing new therapies for patients with leukemia
>
MaRS Programming
Jul 28, 2011
MaRS Future of Medicine™
Adventures in Private Biotech Financing – A company perspective
>
MaRS Programming
May 26, 2011
MaRS Future of Medicine™
Lessons from the Device Battlefield
>
MaRS Programming
Apr 29, 2011
MaRS Future of Medicine™
What does Pharma want, anyway? Presenting your opportunity effectively
>
MaRS Programming
Mar 31, 2011
MaRS Future of Medicine™
Private capital for life science companies
>
MaRS Programming
Feb 24, 2011
MaRS Future of Medicine™
CCRM: Open source innovation in regenerative medicine
>
MaRS Programming
Dec 02, 2010
MaRS Future of Medicine™
MaRS Future of Medicine Conference 2010
>
MaRS Programming
Dec 01, 2010
MaRS Future of Medicine™
What you need to know about regulatory affairs
>
MaRS Programming
Nov 01, 2010
MaRS Future of Medicine™
The View from Bay Street
>
MaRS Programming
Sep 10, 2010
MaRS Future of Medicine™
Anticipating a world in which pharmaceutical companies outsource all R&D
>
MaRS Programming
Aug 24, 2010
MaRS Future of Medicine™
QANTD (Quick And Not Too Dirty) Forecasting
>
 
Jul 26, 2010
MaRS Future of Medicine™
Lessons Learned as an Entrepreneur
>
MaRS Programming
Jun 04, 2010
MaRS Future of Medicine™
Cytochrome-targeted therapeutics for chronic kidney disease
>
MaRS Programming
May 27, 2010
MaRS Future of Medicine™
International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters
>
MaRS Programming
Apr 05, 2010
MaRS Future of Medicine™
A new approach to the treatment of liver cancer
>
MaRS Programming
Mar 12, 2010
MaRS Future of Medicine™
Predicting disease outcome via gene expression analysis
>
MaRS Programming
Feb 12, 2010
MaRS Future of Medicine™
Leading 21st century health care, non-invasive treatment for prostate cancer
>
MaRS Programming
Dec 02, 2009
MaRS Future of Medicine™
Health Economic and Reimbursement Implications for Emerging Pharmaceutical/ Biotechnology Companies: Strategies and perspectives
>
MaRS Programming
Nov 13, 2009
MaRS Future of Medicine™
Targeting Alzheimer’s Disease Progression – from a lead molecule to clinical development
>
MaRS Programming
Nov 12, 2009
MaRS Future of Medicine™
MaRS Future of Medicine Conference
>
MaRS Programming
Oct 09, 2009
MaRS Future of Medicine™
Human pluripotent stem cells for drug discovery
>
 
Sep 17, 2009
MaRS Future of Medicine™
Revitalizing drug discovery with in vivo screening
>
MaRS Programming
Sep 11, 2009
MaRS Future of Medicine™
CHEMSAS® system for drug lead optimization
>
MaRS Programming
Jul 06, 2009
MaRS Future of Medicine™
Disease specific epitopes immunotherapies
>
MaRS Programming
Jun 01, 2009
MaRS Future of Medicine™
Controlled trans-lymphatic chemotherapy for the treatment of lymphatic metastasis in lung cancer
>
MaRS Programming
May 15, 2009
MaRS Future of Medicine™
Overcoming process development and biologics manufacturing challenges
>
MaRS Programming
Dec 16, 2008
MaRS Future of Medicine™
Is there a place for in-vivo pharmacology in modern drug discovery?
>
MaRS Programming
Mar 27, 2008
MaRS Future of Medicine™
Structure-Guided Discovery Without Structures: Computer-aided design of GPCR ligands
>
MaRS Programming
Feb 27, 2008
MaRS Future of Medicine™
Formulation: Giving new life to naturally occurring un-patentable compounds
>
MaRS Programming
Jan 25, 2008
MaRS Future of Medicine™
Novel therapeutic targets for preventing bone loss in osteolytic disease
>
MaRS Programming
Dec 18, 2007
MaRS Future of Medicine™
Outsourcing Preclinical Development
>
MaRS Programming
Oct 23, 2006
MaRS Future of Medicine™
Chance and Necessity in Drug Discovery: The case history of calcimimetic drugs
>
MaRS Programming
Aug 31, 2006
MaRS Future of Medicine™
Structure-based Lead Generation and Optimization
>
MaRS Programming
Jun 29, 2006
>
MaRS Programming
Apr 27, 2006
MaRS Future of Medicine™
BioMarkers in Clinical Trials
>
 
 
 
Get More From MaRS   MaRS NEWSLETTERS
Facebook Twitter Vimeo Flickr

MaRS Charitable Registration Number
876682717 RR0001

Please enter your email address to subscribe to our newsletter